Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam Sedation Dosage in Obese Patients Undergoing Arthroplasty
NCT05760534Phase 4Completed
- Sponsor
- Seoul National University Hospital
- Start
- Mar 2023
- Primary completion
- Nov 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of remimazolam (2 arms), sponsored by Seoul National University Hospital. Primary endpoint: Incidence of intraoperative respiratory depression. Started Mar 2023; status: completed.
02
Drugs
remimazolam
Beyond the preview
Go deeper on NCT05760534.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05760534.